Human Norovirus Bivalent GI.1/GII.4 Recombinant Vaccine

Norovirus vaccine (GI.1/GII.4) · National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Norovirus Bivalent GI.1/GII.4 Recombinant Vaccine, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha) [Phase 3]

See pricing